1. Market Research
  2. > Healthcare Market Trends
  3. > Diagnostics

Medical Diagnostics Industry Overview: Latest Market Reports & Studies

  • Currently 4/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
13 votes

Global Diagnostics Industry

The diagnostics industry involves testing patients to detect disease. Diagnosis can be used in the case of patients already presenting symptoms of disease, to screen asymptomatic patients as a matter of routine, and to allow ongoing testing in patients with disease to establish prognosis or check progress of therapy. The section is part of the wider healthcare industry.

The market can be broadly divided into:

  1. In vitro diagnostics (IVD), which refers to testing samples of blood, tissue, for example electrocardiography; and
  2. Diagnostic imaging, such as x-rays, computerized axial tomography (CAT), mammograms and magnetic resonance imaging (MRI).

Leading Market Segment

The IVD market, estimated at $44 billion in 2010, is predicted to reach $52 billion by 2013 with a compound annual grown rate of approximately 5%, according to research from RNCOS. A particularly profitable growth sector within IVD, molecular diagnostics is predicted to reach $15 billion by 2014 at a compound annual growth rate of just under 20% reports Renub Research. Infectious diseases account for more than a fifth of this segment, followed by oncology testing. By 2014 blood testing and genetic screening together will account for over a quarter of the market, with the US representing $6 billion of the molecular diagnostics market by that time.

Blood grouping reagent Export

Diagnostics Industry Regional Market Share

The In Vitro Diagnostic market is dominated by the US and the EU, which combined comprise about three quarters of the global market. This is because developed countries are witnessing a proliferation of diet and lifestyle related diseases such as cancer, diabetes and cardiovascular disease, whereas developing countries are more concerned with the diagnosis of infection and infectious disease.

In the lead, the IVD market in the US is forecast to grow 5.4% annually, reaching $23 billion in 2013. According to Global Industry Analysts, the US molecular diagnostics market will be over $6.35 billion by 2015.

Following behind, the EU represents the second-largest regional market, with its infectious-disease testing market estimated to reach $1.02 billion in 2012. There is strong growth in oncology testing and pharmacogenomics, which are predicted to show a compound annual growth rate of 10.71% and 11.05%, respectively, between 2011 and 2015.

Top 3 Medical Diagnostics Players

Roche is the market leader in IVD, holding approximately 20% of total market share, followed by Abbott and Siemens, each holding more than 10%.

Roche’s 20% market share represents yearly sales of $44 billion, with key products such as CoaguChek and Accu-Chek fueling the company’s growth. Roche saw 20% growth in Asia-Pacific alone and a 5% rise in the US. Acquisitions, such as in diabetes care (Medingo Ltd) and tissue diagnostics (Biolmagene Inc), should see continued market growth for Roche going forward.

In business for over 120 years, Abbott's sales in 2010 reached over $35 billion, and it invested $3.7 billion in R&D. Its main area of expertise in diagnostics is immunodiagnostics. Abbott's immunoassay diagnostic systems, AxSYM, is used to test for cardiovascular disease, cancer, infectious diseases and thyroid conditions.

Read more »

Share
24/7 Customer Support

Talk to Sam

+1 718 473 0872

1-10 of about 500 reports

Global Diagnostics Industry

  • June 2016
    27 pages
  • Diagnostics  

  • World  

    Puerto Rico  

    Asia  

View report >

Diagnostics Markets in the US

  • April 2016
    18 pages
  • United States  

View report >

Diagnostics Markets in Europe

  • January 2016
    18 pages
  • Europe  

View report >

Diagnostics Industry in Germany

  • January 2014
    11 pages
  • Germany  

    Europe  

View report >

Diagnostics Industry in the UK

  • October 2016
    10 pages
  • Diagnostics  

  • United Kingdom  

View report >

Diagnostics Industry in Canada

  • November 2016
    9 pages
  • Diagnostics  

  • Canada  

View report >

Diagnostics Industry in India

  • January 2016
    9 pages
  • Diagnostics  

  • India  

View report >

Diagnostics Industry in China

  • December 2015
    16 pages
  • Diagnostics  

  • China  

View report >

Diagnostics Industry in South Africa

  • October 2016
    6 pages
  • Diagnostics  

  • South Africa  

    Africa  

View report >

The future of the Diagnostics Industry in South Africa

  • January 2016
    11 pages
  • Diagnostics  

  • South Africa  

View report >


About 3700 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 87 - $ 21100)

Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Tumor Markers: Supplier Shares By Test, Competitive Str ...

October 2016 $ 21100

Europe Microbiology Automated Market

October 2016 $ 12900

Europe Microbiology Market 2017-2021: France, Germany, ...

December 2016 $ 12900

2016 Competing In The Global Enteric Disease Testing Ma ...

October 2016 $ 11500

2016 Competing In The Global Respiratory Disease Testin ...

October 2016 $ 9850

2016 Competing In The Global Sexually-transmitted Disea ...

October 2016 $ 9600

Abbott Competitive Position, Sales And Market Shares B ...

September 2016 $ 8000

U.s. Infectious Diseases In Hospitals, Labs, Blood Bank ...

September 2016 $ 7500

Enteric Diseases: Campylobacter, Cryptosporidium, E. Co ...

September 2016 $ 7500

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.